OpenEye's Katarína Stan?iaková is giving a flash talk and presenting her poster "Development-ability of Antibody Therapeutics" at the 2nd Nordic Conference on Computational Chemistry! If you're attending the conference, don’t miss the chance to check out her poster and chat with our team. Apotekarsocieteten #DrugDevelopment
关于我们
OpenEye, Cadence Molecular Sciences is an industry leader in computational molecular design based on decades of delivering rapid, robust, and scalable software, toolkits, and technology and design services across the drug discovery process. Our scientific approach has focused on visualizing and analyzing the shape and electrostatics of molecular 3D structures to inform and guide the advancement of pharmaceuticals and biotechnology. OpenEye integrated its applications and toolkits into Orion, the only cloud-native, fully integrated molecular design platform. Combining unlimited computation and storage with powerful tools for data sharing, visualization and analysis in an open development platform, Orion offers unprecedented capabilities for drug discovery and optimization. Founded in 1997, OpenEye was acquired by Cadence Design Systems (NASDAQ: CDNS) in August 2022. OpenEye is headquartered in Santa Fe, New Mexico, with offices in Boston, Massachusetts; Cologne, Germany; and Tokyo, Japan.
- 网站
-
https://www.eyesopen.com
OpenEye, Cadence Molecular Sciences的外部链接
- 所属行业
- 软件开发
- 规模
- 51-200 人
- 总部
- Santa Fe，NM
- 类型
- 上市公司
- 创立
- 1997
- 领域
- molecular modeling、virtual screening、shape、electrostatics、cheminformatics、visualization、statistics、cloud computing、SaaS、HPC、AWS partner、computational chemistry、docking、protein-ligand interaction、CADD、drug discovery、large scale virtual screening和crystal structure prediction
地点
OpenEye, Cadence Molecular Sciences员工
动态
-
Join us at Cocktails and Molecules during ACS Spring 2025 in San Diego for an exclusive evening of networking, cocktails, and hors d’oeuvres! ?? Date: Wednesday, March 26, 2025 ? Time: 6 - 9 PM PST #ACS2025 #drugdiscovery
-
?? CUP XXIV is officially underway! We're looking forward to a great meeting featuring talks about the latest advancements in drug discovery from scientists in industry and academia. Cadence #CUPXXIV #drugdiscovery
-
-
OpenEye's Arghya Chakravorty will present "From a few billions to a few: Computer-Aided Drug design on the Cloud" at The University of New Mexico Department of Chemistry and Chemical Biology's Weekly Seminar series today. The talk will present solutions to a variety of problems in the drug discovery process that are widely used in industry with a focus on the contribution that free energy estimation by molecular dynamics (MD) simulation can make to molecular design, and the utility of cloud computing in enabling MD simulation at scale.
-
The full agenda for CUP XXIV is now available! Join us for an exciting lineup of talks and discussions on the latest breakthroughs and challenges in drug discovery. We can’t wait for a fantastic week of science in Santa Fe—see you there! #CUPXXIV #DrugDiscovery
-
When coupled with a physics-based approach, AI is an effective tool for drug discovery. Watch Anthony Nicholls, PhD, discuss how to best utilize AI in early-stage drug discovery process. Cadence #drugdiscovery #aidrugdiscovery #lifesciences
-
We are excited to be attending the BMCS 2nd Conformational Design in Drug Discovery 2025 on March 3rd in Cambridge! Let’s connect and discuss how our cutting-edge molecular modeling solutions can accelerate your research! See you there! #DrugDiscovery #MolecularModeling
-
Watch: Geoff Skillman, PhD discusses the CUP XXIV agenda and keynote speakers. There is still time to register to attend CUP! CUP XXIV ?? March 4-6th ?? Santa Fe, New Mexico Register: https://lnkd.in/eXu6puvq
-
Upcoming Webinar: Optimizing lead compounds with efficient binding free energy calculations Join us on February 20th as we explore how OpenEye’s cloud-native modeling platform, Orion?, enables more accurate and efficient ligand ranking for lead optimization using nonequilibrium switching (NES). ?? Save your spot today! #DrugDiscovery #ComputationalChemistry #MolecularModeling
-
Did you know that OpenEye builds custom software around your specific drug discovery needs? Learn about Feature Acceleration Agreements (FAA) now! https://lnkd.in/edxkqjYm